Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach

VRC01 is a first-in-class, potent, broadly neutralizing antibody that targets the CD4 binding site of gp120 on HIV-1 viruses, and is under development as a novel HIV therapeutic. This study utilized population pharmacokinetic modeling to characterize VRC01 pharmacokinetics to guide dosing selection...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Pharmacol Ther
Main Authors: Li, Jerry, Nikanjam, Mina, Cunningham, Coleen K., McFarland, Elizabeth J., Coates, Emily E., Houser, Katherine V., Lin, Bob C., McDermott, Adrian B., Flach, Britta, Gama, Lucio, Koup, Richard A., Graham, Barney S., Mascola, John R., Ledgerwood, Julie E., Capparelli, Edmund V.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7902301/
https://ncbi.nlm.nih.gov/pubmed/32866318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.2026
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados